OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Microorganisms-derived antigens for preventive anti-cancer vaccines
Luigi Buonaguro, Beatrice Cavalluzzo, Angela Mauriello, et al.
Molecular Aspects of Medicine (2023) Vol. 92, pp. 101192-101192
Closed Access | Times Cited: 9
Luigi Buonaguro, Beatrice Cavalluzzo, Angela Mauriello, et al.
Molecular Aspects of Medicine (2023) Vol. 92, pp. 101192-101192
Closed Access | Times Cited: 9
Showing 9 citing articles:
Peptide-based vaccine for cancer therapies
Luigi Buonaguro, Maria Tagliamonte
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 43
Luigi Buonaguro, Maria Tagliamonte
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 43
Cross-reactive CD8+ T cell responses to tumor-associated antigens (TAAs) and homologous microbiota-derived antigens (MoAs)
Beatrice Cavalluzzo, Marie Christine Viuff, Siri Tvingsholm, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 6
Beatrice Cavalluzzo, Marie Christine Viuff, Siri Tvingsholm, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 6
Mimicry-based strategy between human and commensal antigens for the development of a new family of immune therapies for cancer
Alice Talpin, Ana Maia, Jean-Marie Carpier, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 2, pp. e010192-e010192
Open Access
Alice Talpin, Ana Maia, Jean-Marie Carpier, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 2, pp. e010192-e010192
Open Access
Epigenetic regulators combined with tumour immunotherapy: current status and perspectives
Huan Zhang, Yuepeng Pang, Ling Yi, et al.
Clinical Epigenetics (2025) Vol. 17, Iss. 1
Open Access
Huan Zhang, Yuepeng Pang, Ling Yi, et al.
Clinical Epigenetics (2025) Vol. 17, Iss. 1
Open Access
GFPBW1, a β-glucan from Grifola frondosa as vaccine adjuvant: APCs activation and maturation
X. He, Jiang-ling Lu, Wenfeng Liao, et al.
Acta Pharmacologica Sinica (2024) Vol. 45, Iss. 11, pp. 2394-2404
Closed Access | Times Cited: 2
X. He, Jiang-ling Lu, Wenfeng Liao, et al.
Acta Pharmacologica Sinica (2024) Vol. 45, Iss. 11, pp. 2394-2404
Closed Access | Times Cited: 2
A Mimicry-Based Strategy Between Human and Commensal Antigens for the Development of a New Family of Immune Therapies for Cancer
Alice Talpin, Ana Maia, Jean-Marie Carpier, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Alice Talpin, Ana Maia, Jean-Marie Carpier, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Molecular mimicry of SARS-COV-2 antigens as a possible natural anti-cancer preventive immunization
Concetta Ragone, Angela Mauriello, Beatrice Cavalluzzo, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Concetta Ragone, Angela Mauriello, Beatrice Cavalluzzo, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Advancing Tumor Vaccines: Overcoming TME Challenges, Delivery Strategies, and Biomaterial-based Vaccine for Enhanced Immunotherapy
Qingsong Zeng, Shibo Zhang, Ning Leng, et al.
Critical Reviews in Oncology/Hematology (2024), pp. 104576-104576
Closed Access
Qingsong Zeng, Shibo Zhang, Ning Leng, et al.
Critical Reviews in Oncology/Hematology (2024), pp. 104576-104576
Closed Access
Vaccines for cancer prevention and treatment
Federica Cavallo, Pier‐Luigi Lollini
Molecular Aspects of Medicine (2024), pp. 101334-101334
Closed Access
Federica Cavallo, Pier‐Luigi Lollini
Molecular Aspects of Medicine (2024), pp. 101334-101334
Closed Access
